ATE205405T1 - Gefriergetrockneter verband - Google Patents

Gefriergetrockneter verband

Info

Publication number
ATE205405T1
ATE205405T1 AT93303360T AT93303360T ATE205405T1 AT E205405 T1 ATE205405 T1 AT E205405T1 AT 93303360 T AT93303360 T AT 93303360T AT 93303360 T AT93303360 T AT 93303360T AT E205405 T1 ATE205405 T1 AT E205405T1
Authority
AT
Austria
Prior art keywords
freeze
dried
weight
parts
dried dressing
Prior art date
Application number
AT93303360T
Other languages
English (en)
Inventor
Catherine L Cheong
Original Assignee
Johnson & Johnson Medical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Medical filed Critical Johnson & Johnson Medical
Application granted granted Critical
Publication of ATE205405T1 publication Critical patent/ATE205405T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0023—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0015—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0021—Plasticisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0031—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0014—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/23—Carbohydrates
    • A61L2300/236—Glycosaminoglycans, e.g. heparin, hyaluronic acid, chondroitin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A61L2300/254—Enzymes, proenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A61L2300/414—Growth factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Materials For Medical Uses (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Medicinal Preparation (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
AT93303360T 1992-04-30 1993-04-29 Gefriergetrockneter verband ATE205405T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929209327A GB9209327D0 (en) 1992-04-30 1992-04-30 Freeze-dried pad

Publications (1)

Publication Number Publication Date
ATE205405T1 true ATE205405T1 (de) 2001-09-15

Family

ID=10714781

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93303360T ATE205405T1 (de) 1992-04-30 1993-04-29 Gefriergetrockneter verband

Country Status (8)

Country Link
US (1) US5441741A (de)
EP (1) EP0568368B1 (de)
AT (1) ATE205405T1 (de)
AU (1) AU663174B2 (de)
BR (1) BR9301698A (de)
CA (1) CA2095077C (de)
DE (1) DE69330727T2 (de)
GB (1) GB9209327D0 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2275686B (en) * 1993-03-03 1997-04-30 Johnson & Johnson Medical Swellable wound dressing materials
GB2275685B (en) * 1993-03-03 1997-04-30 Johnson & Johnson Medical Water soluble wound dressing materials
US5409703A (en) * 1993-06-24 1995-04-25 Carrington Laboratories, Inc. Dried hydrogel from hydrophilic-hygroscopic polymer
GB2291348B (en) * 1994-07-18 1999-01-20 Johnson & Johnson Medical Sterile gel composition for wound treatment comprising alginate and polyhydric alcohol
US7112320B1 (en) 1995-06-07 2006-09-26 Andre Beaulieu Solid wound healing formulations containing fibronectin
GB9608222D0 (en) * 1996-04-20 1996-06-26 Innovative Tech Ltd Dehydrated hydrogels
FR2764505B1 (fr) * 1997-06-13 1999-10-15 Alain Dogliani Nouvelles compositions cosmetiques a base de lyophilisats d'alginates alcalins et nouveaux vecteurs de penetration
US6458341B1 (en) * 1998-06-04 2002-10-01 3M Innovative Properties Company Devices with coatings containing chlorhexidine gluconate, compositions and methods
US6939914B2 (en) 2002-11-08 2005-09-06 Kimberly-Clark Worldwide, Inc. High stiffness absorbent polymers having improved absorbency rates and method for making the same
US6863924B2 (en) * 2002-12-23 2005-03-08 Kimberly-Clark Worldwide, Inc. Method of making an absorbent composite
KR100984184B1 (ko) * 2003-03-18 2010-09-28 에스케이케미칼주식회사 알긴산 스폰지 및 그의 제조방법
DE102005017845A1 (de) * 2005-04-18 2006-10-19 Lohmann & Rauscher Gmbh & Co. Kg Autosterile, antiseptische Kollagenzubereitungen, ihre Verwendung und Verfahren zu ihrer Herstellung
BRPI0800085A2 (pt) * 2008-02-08 2009-09-29 Cruz Luis Eduardo Da composição farmacêutica e curativo para tratamento de lesões de pele, bem como uso de sal de cério associado a uma matriz de colágeno
US8507652B2 (en) * 2008-02-08 2013-08-13 Luis Eduardo da Cruz Pharmaceutical composition, dressing and method for treating skin lesion, intermediate composition and process for preparing said dressing, and use of cerium salt associated with a collagen matrix
CN103442572A (zh) 2011-01-21 2013-12-11 艾利丹尼森公司 含有葡萄糖酸洗必泰的粘合剂
WO2012158483A2 (en) 2011-05-16 2012-11-22 Avery Dennison Corporation Adhesive containing microparticles
KR102242908B1 (ko) 2013-02-07 2021-04-20 애버리 데니슨 코포레이션 개선된 특성을 지니는 항미생물 접착제
JP6893086B2 (ja) 2013-03-13 2021-06-23 エーブリー デニソン コーポレイション 接着特性の向上
US11213432B2 (en) 2013-03-15 2022-01-04 Avery Dennison Corporation Transparent cover dressing application system and inclusion of label strip
US9970303B2 (en) 2014-05-13 2018-05-15 Entrotech, Inc. Erosion protection sleeve
WO2015188031A2 (en) 2014-06-05 2015-12-10 Avery Dennison Corporation Articles with active agent concentrated at the substrate contacting surface and related methods
MX2017004520A (es) 2014-10-14 2018-03-15 Lynch Samuel Composiciones para tratar heridas.
US10188598B1 (en) 2015-11-25 2019-01-29 Sage Products, Llc Sterilized chlorhexidine article and method of sterilizing a chlorhexidine article

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5583710A (en) * 1978-12-20 1980-06-24 Lion Corp Spongy enzyme preparation
US4292972A (en) * 1980-07-09 1981-10-06 E. R. Squibb & Sons, Inc. Lyophilized hydrocolloio foam
NZ216772A (en) * 1985-07-22 1988-09-29 Personal Products Co Preparation of highly absorbent, retentive cellulose pulp; absorbent products containing same
US4965203A (en) * 1987-01-28 1990-10-23 Warner-Lambert Company Purified thrombin preparations
US5206026A (en) * 1988-05-24 1993-04-27 Sharik Clyde L Instantaneous delivery film
DK148790D0 (da) * 1990-06-19 1990-06-19 Novo Nordisk As Farmaceutisk praeparat
US5206028A (en) * 1991-02-11 1993-04-27 Li Shu Tung Dense collagen membrane matrices for medical uses

Also Published As

Publication number Publication date
US5441741A (en) 1995-08-15
BR9301698A (pt) 1993-11-03
DE69330727D1 (de) 2001-10-18
EP0568368A1 (de) 1993-11-03
CA2095077A1 (en) 1993-10-31
DE69330727T2 (de) 2002-07-11
GB9209327D0 (en) 1992-06-17
AU663174B2 (en) 1995-09-28
CA2095077C (en) 2001-04-10
AU3708293A (en) 1993-11-04
EP0568368B1 (de) 2001-09-12

Similar Documents

Publication Publication Date Title
DE69330727D1 (de) Gefriergetrockneter Verband
ES2127744T3 (es) Vendaje de cinta y metodo para su produccion.
AU7625196A (en) Bandaging system
DE69311101D1 (de) Verfahren sowie anordnung zum herstellen von wundverbänden sowie mit diesem verfahren hergestellter wundverband
FI935851A0 (fi) Antiallergisk sammansaettning foer oftalmiskt eller nasalt bruk
SE9303444D0 (sv) New use of prostaglandins
EA199700170A1 (ru) Способ получения некоторых азациклогексапетидов
GR920100459A (el) Μέ?οδοι για τον έλεγχο του πολλαπλασιασμού αν?ρώπινων ενδο?ηλιακών κυττάρων και λειτουργίες εκτελεστή χρησιμοποιώντας την ογκοστατίνη Μ.
NO872002D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive sukralfat-preparater.
CA2101009A1 (en) Production of Sod Using a Soil-Less Sand Based Root Zone Medium
NO179612C (no) Analogifremgangsmåte for fremstilling av 3-arylkarbonyl-1-aminoalkyl-1H-indol-forbindelser
FI872629A0 (fi) Menetelmä vaginansisäisen välineen valmistamiseksi
DE3485100D1 (de) Topische antibiotische zusammensetzung zur behandlung der schleimhaeute.
EP0350878A3 (de) Konjugierte Oxybutenolide zur Behandlung von Ulcera
ATE132039T1 (de) Verwendung von steroidderivaten zur behandlung der endometriose
NO943968D0 (no) Nytt anti-neoplastisk cytokin
DE69131058D1 (de) Verwendung einer therapeutischen Zusammensetzung zur Behandlung von Bronchitis
SU925325A1 (ru) Способ дренировани грудного лимфатического протока
FI924088A7 (fi) Prostaglandiini F3a:n käyttö silmänpainetta laskevana aineena
ATE190468T1 (de) Verfahren zur herstellung antimikrobieller wirkstoffe
IT1243274B (it) Procedimento per l'applicazione dello sperone e calzature costruite secondo il procedimento.
EP0402857A3 (de) Verwendung von 17-beta-Cyclopropylaminoandrosten-Derivaten
ATE145133T1 (de) Verwendung von thiol-5-(2-diethyl-aminoethyl)- ester-verbindungen zur herstellung eines arzneimittels zur behandlung der neuromuskuläre inkontinenz
EP0155214A3 (en) 2-sulfamoyl-1h-indole derivatives for the treatment of elevated intraocular pressure

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties